TRIO and neoplasm: NSC23766, a Rac1 inhibitor that prevents the functions of Rac1 GEFs such as Tiam and Trio, is available in an in vitro experimental setting (Supplementary Fig. S5); thus, the detection of activated Rac1 in tumor tissues would be linked to an option of molecular therapy targeting activated Rac1.